Literature DB >> 11039909

Regulation of proliferation-survival decisions is controlled by FGF1 secretion in retinal pigmented epithelial cells.

M Bryckaert1, X Guillonneau, C Hecquet, P Perani, Y Courtois, F Mascarelli.   

Abstract

Fibroblast growth factor 1 (FGF1) induces proliferation and differentiation in a wide variety of cells of mesodermal and neuroectodermal origin. FGF1 has no 'classical' signal sequence to direct its secretion, and there has been considerable debate concerning FGF1 secretion and its role in the biological activities of FGF1. We investigated the effects of FGF1 secretion and the signalling induced by signal peptide (SP)-containing FGFI and SP-less FGF1, on the proliferation and the apoptosis in retinal pigmented epithelial (RPE) cells. Primary RPE cell cultures were transfected with FGF1 (FGF1 cells) and SP-FGF1 (SP-FGF1 cells) cDNAs. SP-FGF1 cells secreted large amount of FGF1 and actively proliferated, whereas FGF1 and control cells did not. Secreted FGF1 induced short-term activation of both FGFR1 and ERK2, which were required for cell proliferation. In contrast, SP-FGF1 cells stopped secreting FGF1 and died rapidly, if cultured in the absence of serum. Surprisingly, FGF1 cells, but not control cells, secreted FGF1 and were resistant to apoptosis induced by serum depletion. Secreted FGF1 induced long-term activation of FGFR1 and ERK2, which was necessary to induce a constant and high level of Bcl-x production, and to induce cell survival in FGFI cells. Downregulation of ERK2 and Bcl-x increased apoptosis. Thus, the proliferation and survival activities of FGF1 depend on the secretion of FGF1 which is determined by the cell culture conditions. Cell proliferation was SP-dependent, whereas cell survival was not. The signal peptide controls the level and duration, 'whispering or shouting', of ERK2 activation cells which determines FGF1 biological function and may have important implications for anti-degenerative and anti-proliferative treatments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039909     DOI: 10.1038/sj.onc.1203872

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Authors:  Seyed Javad Hoseini; Hamed Ghazavi; Fatemeh Forouzanfar; Baratali Mashkani; Ahmad Ghorbani; Elahe Mahdipour; Faezeh Ghasemi; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  DNA Cell Biol       Date:  2017-03-10       Impact factor: 3.311

2.  Secretome analysis reveals an Arabidopsis lipase involved in defense against Alternaria brassicicola.

Authors:  Il Seok Oh; Ae Ran Park; Min Seok Bae; Sun Jae Kwon; Young Soon Kim; Ji Eun Lee; Na Young Kang; Sumin Lee; Hyeonsook Cheong; Ohkmae K Park
Journal:  Plant Cell       Date:  2005-08-26       Impact factor: 11.277

3.  A computational study of VEGF production by patterned retinal epithelial cell colonies as a model for neovascular macular degeneration.

Authors:  Qanita Bani Baker; Gregory J Podgorski; Elizabeth Vargis; Nicholas S Flann
Journal:  J Biol Eng       Date:  2017-08-02       Impact factor: 4.355

4.  Fibroblast Growth Factor Type 1 Ameliorates High-Glucose-Induced Oxidative Stress and Neuroinflammation in Retinal Pigment Epithelial Cells and a Streptozotocin-Induced Diabetic Rat Model.

Authors:  Hsin-Wei Huang; Chung-May Yang; Chang-Hao Yang
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

5.  Establishing F1A-CreERT2 Mice to Trace Fgf1 Expression in Adult Mouse Cardiomyocytes.

Authors:  Yi-Chao Hsu; Yu-Fen Chung; Mei-Shu Chen; Chi-Kuang Wang; Si-Tse Jiang; Ing-Ming Chiu
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 6.  Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development.

Authors:  Rishika Chaudhary; Robert A H Scott; Graham Wallace; Martin Berry; Ann Logan; Richard J Blanch
Journal:  Transl Vis Sci Technol       Date:  2020-02-21       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.